Clinical Trials Browser

Phase 3 × Prostate Cancer Metastatic × enzalutamide × Clear all

NCT06136624 2026-03-11

OMAHA-003

Phase 3 Recruiting

Prostate Cancer Metastatic

NCT03850795 2024-08-19

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase 3 Terminated

Prostate Cancer Metastatic